Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
8,147
archived clinical trials in
Asthma

A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site 1315
mi
from
Centennial, CO
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site 1315
mi
from
Centennial, CO
Click here to add this to my saved trials
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site 12268
mi
from
Melbourne, FL
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site 12268
mi
from
Melbourne, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site 1345
mi
from
Miami, FL
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site 1345
mi
from
Miami, FL
Click here to add this to my saved trials
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site 10129
mi
from
Walnut Creek, CA
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site 10129
mi
from
Walnut Creek, CA
Click here to add this to my saved trials
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site 10254
mi
from
White Marsh, MD
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site 10254
mi
from
White Marsh, MD
Click here to add this to my saved trials
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site 10511
mi
from
Warwick, RI
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site 10511
mi
from
Warwick, RI
Click here to add this to my saved trials
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site
mi
from
Oklahoma City, OK
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site 32326
mi
from
Berlin,
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site 32326
mi
from
Berlin,
Click here to add this to my saved trials
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site 10552
mi
from
Saint Louis, MO
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site 10552
mi
from
Saint Louis, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site 10827
mi
from
Warrensburg, MO
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site 10827
mi
from
Warrensburg, MO
Click here to add this to my saved trials
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated:  1/4/2018
Teva Investigational Site 14652
mi
from
Ocean City, NJ
A Safety and Efficacy Study of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Participants >=12 Years Old With Persistent Asthma
A Randomized, Double-Blind, Double-Dummy, Placebo Controlled, Parallel-Group, 12-Week Clinical Study to Assess the Efficacy and Safety of 320 or 640 mcg/Day of Beclomethasone Dipropionate Delivered Via Breath-Actuated Inhaler (BAI) or Metered-Dose Inhaler (MDI) in Adolescent and Adult Patients 12 Years of Age and Older With Persistent Asthma
Status: Enrolling
Updated: 1/4/2018
Teva Investigational Site 14652
mi
from
Ocean City, NJ
Click here to add this to my saved trials
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Birmingham, AL
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Los Angeles, CA
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Cincinnati, OH
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Orangeburg, SC
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Orangeburg, SC
Click here to add this to my saved trials
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Medford, OR
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Medford, OR
Click here to add this to my saved trials
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated:  1/5/2018
GSK Investigational Site
mi
from
Sainte-Foy,
Study of Mepolizumab Safety Syringe in Asthmatics
An Open-label, Single Arm, Repeat Dose, Multi-centre Study to Evaluate the Use of a Safety Syringe for the Subcutaneous Administration of Mepolizumab in Subjects With Severe Eosinophilic Asthma (Study 205667)
Status: Enrolling
Updated: 1/5/2018
GSK Investigational Site
mi
from
Sainte-Foy,
Click here to add this to my saved trials
Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Status: Enrolling
Updated:  1/8/2018
Clinical Study Site
mi
from
Huntington Beach, CA
Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Status: Enrolling
Updated: 1/8/2018
Clinical Study Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Status: Enrolling
Updated:  1/8/2018
Teva Clinical Study Site
mi
from
Lakewood, CO
Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Status: Enrolling
Updated: 1/8/2018
Teva Clinical Study Site
mi
from
Lakewood, CO
Click here to add this to my saved trials
Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Status: Enrolling
Updated:  1/8/2018
Clinical Study Site
mi
from
Minneapolis, MN
Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Status: Enrolling
Updated: 1/8/2018
Clinical Study Site
mi
from
Minneapolis, MN
Click here to add this to my saved trials
Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Status: Enrolling
Updated:  1/8/2018
Clinical Study Site
mi
from
Oklahoma City, OK
Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Status: Enrolling
Updated: 1/8/2018
Clinical Study Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Status: Enrolling
Updated:  1/8/2018
Clinical Study Site
mi
from
Lake Oswego, OR
Comparison of Single-Dose of Albuterol Breath Activated Inhaler Versus Albuterol Metered Dose Inhaler in Asthmatics
Comparison of Single-Dose Efficacy of Albuterol-HFA-BAI and Albuterol-HFA-MDI in Asthmatics With Poor Inhaler Coordinating Ability
Status: Enrolling
Updated: 1/8/2018
Clinical Study Site
mi
from
Lake Oswego, OR
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
New Haven, CT
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
New Haven, CT
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Charleston, SC
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Charleston, SC
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Long Beach, CA
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Los Angeles, CA
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Riverside, CA
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Riverside, CA
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
San Diego, CA
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
San Diego, CA
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Denver, CO
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Denver, CO
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Albany, GA
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Albany, GA
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Columbus, GA
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Columbus, GA
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Lexington, KY
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Lexington, KY
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Winston-Salem, NC
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Canton, OH
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Canton, OH
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Cleveland, OH
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Cleveland, OH
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Oklahoma City, OK
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Oklahoma City, OK
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Hershey, PA
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Hershey, PA
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Nashville, TN
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Nashville, TN
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Boerne, TX
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Boerne, TX
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Houston, TX
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Madison, WI
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Madison, WI
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Mar del Plata,
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Mar del Plata,
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Saint Louis, MO
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Pittsburgh, PA
Dose Ranging Efficacy And Safety With Mepolizumab in Severe Asthma
A Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel Group, Dose Ranging Study to Determine the Effect of Mepolizumab on Exacerbation Rates in Subjects With Severe Uncontrolled Refractory Asthma
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Bell Gardens, CA
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Bell Gardens, CA
Click here to add this to my saved trials
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Huntington Beach, CA
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Huntington Beach, CA
Click here to add this to my saved trials
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Long Beach, CA
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Long Beach, CA
Click here to add this to my saved trials
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Los Angeles, CA
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Newport Beach, CA
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Newport Beach, CA
Click here to add this to my saved trials
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated:  1/18/2018
GSK Investigational Site
mi
from
Riverside, CA
Study HZA106827: Efficacy/Safety Study of Fluticasone Furoate/Vilanterol (GW642444) in Adult and Adolescent Asthmatics
HZA106827: A Randomised, Double-blind, Placebo-controlled (With Rescue Medication), Parallel Group Multicentre Study of Fluticasone Furoate/GW642444 Inhalation Powder and Fluticasone Furoate Inhalation Powder Alone in the Treatment of Persistent Asthma in Adults and Adolescents
Status: Enrolling
Updated: 1/18/2018
GSK Investigational Site
mi
from
Riverside, CA
Click here to add this to my saved trials